Product Name:2-(6-Bromopyridin-2-yl)propan-2-ol

IUPAC Name:2-(6-bromopyridin-2-yl)propan-2-ol

CAS:638218-78-7
Molecular Formula:C8H10BrNO
Purity:95%+
Catalog Number:CM102529
Molecular Weight:216.08

Packing Unit Available Stock Price($) Quantity
CM102529-5g in stock Ƌdžſ
CM102529-10g in stock ȌǠdž
CM102529-25g in stock ƤDzȷ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:638218-78-7
Molecular Formula:C8H10BrNO
Melting Point:-
Smiles Code:CC(O)(C1=NC(Br)=CC=C1)C
Density:
Catalog Number:CM102529
Molecular Weight:216.08
Boiling Point:
MDL No:MFCD16657880
Storage:Store at 2-8°C.

Category Infos

Pyridines
Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.
Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu
Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer
Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.

Column Infos

Wee1 inhibitors
Wee1 protein is the most well-known Wee protein, and Wee1 protein kinases are members of the serine/threonine family and are highly conserved in evolution and are abundantly present in many eukaryotes and are very active in the S and G2 phases of the cell cycle. Wee1 protein kinase is a key regulatory center in DNA replication, chromosomal concentration, and histone transcription. These biological behavioral abnormalities can lead to genomic instability and cause malignant tumors, but inhibition or down-regulation of Wee1 protein kinase expression in malignant tumors can trigger mitotic catastrophe and apoptosis leads to tumor cell death. It has now been found that the expression of Wee1 is up-regulated in many cancers, and it has been clinically found that treatment with an inhibitor of Wee1 can effectively improve the occurrence and development of cancer. At present, many companies have deployed this target, and some have progressed to the clinical stage. Some Wee1 inhibitors under development include Adavosertib(ADZ1775), Azenosertib, ZNL-06-096, Debio-0123 and SGR-3515.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.

Related Products